{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:47:56Z","timestamp":1759366076259,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T00:00:00Z","timestamp":1548806400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atenci\u00f3n Primaria"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.aprim.2019.01.005","type":"journal-article","created":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T07:30:14Z","timestamp":1559374214000},"page":"327-334","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["De la vigilancia a la acci\u00f3n: modificando conductas terap\u00e9uticas en la infecci\u00f3n gonoc\u00f3cica"],"prefix":"10.1016","volume":"52","author":[{"given":"Mar\u00eda Jes\u00fas","family":"Purri\u00f1os-Hermida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Losada Castillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1nxela","family":"Pousa Ortega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d3scar","family":"Paz Montero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elvira","family":"Amado Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Malvar Pintos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.aprim.2019.01.005_bib0125","doi-asserted-by":"crossref","first-page":"e1002366","DOI":"10.1371\/journal.pmed.1002366","article-title":"Multidrug-resistant gonorrhea: A research and development roadmap to discover new medicines","volume":"14","author":"Alirol","year":"2017","journal-title":"PLoS Med."},{"key":"10.1016\/j.aprim.2019.01.005_bib0130","unstructured":"World Health Organization (WHO). WHO Treatment of Neisseria gonorrhoeae. 2016. [consultado 12 Dic 2017]. Disponible en: http:\/\/apps.who.int\/iris\/bitstream\/10665\/246114\/1\/9789241549691-eng.pdf?ua=1"},{"key":"10.1016\/j.aprim.2019.01.005_bib0135","unstructured":"Sistema de Informaci\u00f3n Microbiol\u00f3gica. Centro Nacional de Epidemiolog\u00eda. Instituto de Salud Carlos III. Informe anual del Sistema de Informaci\u00f3n Microbiol\u00f3gica 2016. Madrid; 2017. [consultado 8 Dic 2017]. Disponible en: http:\/\/www.isciii.es\/ISCIII\/es\/contenidos\/fd-servicios-cientifico-tecnicos\/fd-vigilancias-alertas\/fd-sistema-informacion-microbiologica\/pdf_2017\/SIM_2016_provisional.pdf"},{"key":"10.1016\/j.aprim.2019.01.005_bib0140","unstructured":"[datos] European Centre for Disease Prevention and Control (ECDC). Disease data from ECDC surveillance atlas-gonorrhoea. 2017. [consultado 12 Dic 2018]. Disponible en: https:\/\/ecdc.europa.eu\/en\/gonorrhoea\/surveillance-and-disease-data\/disease-data-atlas"},{"key":"10.1016\/j.aprim.2019.01.005_bib0145","unstructured":"Direcci\u00f3n Xeral de Sa\u00fade P\u00fablica de Galicia (DXSP). A infecci\u00f3n gonoc\u00f3cica en Galicia en 2017. Bolet\u00edn Epidemiol\u00f3xico de Galicia 2018;XXX(4). [consultado 10 Dic 2017]. Disponible en: https:\/\/www.sergas.es\/Saudepublica\/Documents\/5563\/BEG%20XXX-4.pdf"},{"key":"10.1016\/j.aprim.2019.01.005_bib0150","unstructured":"World Health Organization (WHO). Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae. 2012. [consultado 7 Dic 2017]. Disponible en: http:\/\/apps.who.int\/iris\/bitstream\/10665\/44863\/1\/9789241503501_eng.pdf"},{"key":"10.1016\/j.aprim.2019.01.005_bib0155","unstructured":"European Centre for Disease Prevention and Control. Response plan to control and manage thethreat of multidrug-resistant gonorrhoea in Europe. Stockholm: ECDC; 2012. doi 10.2900\/60053. [consultado 5 Dic 2017]. Disponible en: https:\/\/ecdc.europa.eu\/sites\/portal\/files\/media\/en\/publications\/Publications\/1206-ECDC-MDR-gonorrhoea-response-plan.pdf"},{"key":"10.1016\/j.aprim.2019.01.005_bib0160","doi-asserted-by":"crossref","unstructured":"Unemo M, on behalf of the European STI Guidelines Editorial Board Collective. The \u20182012 European guidelines on the diagnosis and treatment of gonorrhoea in adults\u2019 recommends dual antimicrobial therapy. Euro Surveill. 2012;17(47):pii=20323, https:\/\/doi.org\/10.2807\/ese.17.47.20323-en","DOI":"10.2807\/ese.17.47.20323-en"},{"key":"10.1016\/j.aprim.2019.01.005_bib0165","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.2217\/fmb.12.117","article-title":"Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea","volume":"7","author":"Unemo","year":"2012","journal-title":"Future Microbiol."},{"key":"10.1016\/j.aprim.2019.01.005_bib0170","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1128\/AAC.00325-11","article-title":"Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea? Detailed characterization of the first strain with high-level resistance to ceftriaxone","volume":"55","author":"Ohnishi","year":"2011","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.aprim.2019.01.005_bib0175","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1128\/AAC.05760-11","article-title":"High-level cefixime- and ceftriaxone-resistant N. gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure","volume":"56","author":"Unemo","year":"2012","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.aprim.2019.01.005_bib0180","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1093\/jac\/dks162","article-title":"Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia Spain","volume":"67","author":"C\u00e1mara","year":"2012","journal-title":"J Antimicrob Chemother."},{"key":"10.1016\/j.aprim.2019.01.005_bib0185","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2018.23.27.1800323","article-title":"Gonorrhoea treatment failure caused by a Neisseria gonorrhoeae strain with combined ceftriaxone and high-level azithromycin resistance, England, February 2018","volume":"23","author":"Eyre","year":"2018","journal-title":"Euro Surveill."},{"key":"10.1016\/j.aprim.2019.01.005_bib0190","unstructured":"European Centre for Disease Prevention and Control. Extensively drug-resistant (XDR) Neisseria gonorrhoeae in the United Kingdom and Australia \u2013 7 May 2018. Stockholm: ECDC; 2018 [consultado 22 Nov 2018]. Disponible en: https:\/\/ecdc.europa.eu\/sites\/portal\/files\/documents\/RRA-Gonorrhoea%2C%20Antimicrobial%20resistance-United%20Kingdom%2C%20Australia.pdf"},{"key":"10.1016\/j.aprim.2019.01.005_bib0195","unstructured":"Direcci\u00f3n Xeral de Sa\u00fade P\u00fablica de Galicia. Venres Epidemiol\u00f3xico. 2014-2017. [consultado 20 Oct 2018]. Disponible en: https:\/\/www.sergas.es\/Saude-publica\/Venres--Gonococia;"},{"key":"10.1016\/j.aprim.2019.01.005_bib0200","unstructured":"World Health Organization (WHO). Antibiotic resistance; 5 febrero 2018. [consultado 21 Feb 2018]. Disponible en: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/antibiotic-resistance"},{"key":"10.1016\/j.aprim.2019.01.005_bib0205","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.3201\/eid2310.170488","article-title":"Antimicrobial Drug Prescription and Neisseria gonorrhoeae Susceptibility, United States, 2005-2013","volume":"23","author":"Kirkcaldy","year":"2017","journal-title":"Emerg Infect Dis."},{"key":"10.1016\/j.aprim.2019.01.005_bib0210","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0213-005X(02)72762-6","article-title":"Neisseria gonorrhoeae resistente a quinolonas: un nuevo problema de salud p\u00fablica en Espa\u00f1a","volume":"20","author":"Otero","year":"2002","journal-title":"Enferm Infecc Microbiol Clin."},{"key":"10.1016\/j.aprim.2019.01.005_bib0215","unstructured":"Centro Nacional de Epidemiolog\u00eda. Instituto de Salud Carlos III. Red Nacional de Vigilancia Epidemiol\u00f3gica. Protocolos de la Red Nacional de Vigilancia Epidemiol\u00f3gica. Madrid, 2013. [consultado 18 Oct 2017]. Disponible en: http:\/\/www.isciii.es\/ISCIII\/es\/contenidos\/fd-servicios-cientifico-tecnicos\/fd-vigilancias-alertas\/fd-procedimientos\/PROTOCOLOS_RENAVE-ciber.pdf"},{"key":"10.1016\/j.aprim.2019.01.005_bib0220","unstructured":"WHO. Gu\u00edas para el tratamiento de las infecciones de transmisi\u00f3n sexual. 2005. [consultado 12 Mar 2017]. Disponible en: http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/43188\/9243546260_spa.?sequence=1"},{"key":"10.1016\/j.aprim.2019.01.005_bib0225","unstructured":"The Gonococcal Resistance to Antimicrobials Surveillance Programme. The GRASP 2013 report. 2013. [consultado 3 Dic 2017]. Disponible en: https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/368477\/GRASP_Report_2013.pdf"},{"key":"10.1016\/j.aprim.2019.01.005_bib0230","unstructured":"The Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP). Surveillance of antimicrobial resistance in Neisseria gonorrhoeae in England and Wales: Key findings from the Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP). 2017. [consultado 17 Dic 2017]. Disponible en: https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/651636\/GRASP_Report_2017.pdf"},{"key":"10.1016\/j.aprim.2019.01.005_bib0235","unstructured":"Centers for Disease Control and Prevention (CDC). Sexually Transmitted Disease Surveillance 2017. Gonorrhea. 2018. [consultado 1 Dic 2017]. Disponible en: https:\/\/www.cdc.gov\/std\/stats17\/gonorrhea.htm"},{"key":"10.1016\/j.aprim.2019.01.005_bib0240","article-title":"Gonococcal infections and emergence of gonococcal decreased susceptibility to cephalosporins in France, 2001 to 2012","volume":"19","author":"La Ruche","year":"2014","journal-title":"Euro Surveillance."}],"container-title":["Atenci\u00f3n Primaria"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212656718306620?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212656718306620?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T12:58:15Z","timestamp":1759323495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0212656718306620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0212656718306620"],"URL":"https:\/\/doi.org\/10.1016\/j.aprim.2019.01.005","relation":{},"ISSN":["0212-6567"],"issn-type":[{"type":"print","value":"0212-6567"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"De la vigilancia a la acci\u00f3n: modificando conductas terap\u00e9uticas en la infecci\u00f3n gonoc\u00f3cica","name":"articletitle","label":"Article Title"},{"value":"Atenci\u00f3n Primaria","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aprim.2019.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}